Cozad Asset Management Inc
Source: SEC Form 13F · as of Mar 2026Cozad Asset Management Inc holds 18 biotech & pharma companies tracked by BioSniper, totaling $58.6M in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$58.6M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 22,031 | $20.3M |
| CORCencora Inc. | 26,820 | $8.4M |
| CAHCardinal Health Inc. | 34,703 | $7.3M |
| JNJJOHNSON & JOHNSON | 17,785 | $4.3M |
| ABBVAbbVie Inc. | 15,945 | $3.5M |
| MRKMerck & Co., Inc. | 21,181 | $2.5M |
| DGXQuest Diagnostics Incorporated | 11,529 | $2.3M |
| PMPhilip Morris International Inc | 13,417 | $2.2M |
| UTHRUNITED THERAPEUTICS Corp | 2,980 | $1.8M |
| ABTABBOTT LABORATORIES | 12,471 | $1.3M |
| AZNASTRAZENECA PLC | 6,560 | $1.3M |
| PFEPFIZER INC | 35,164 | $987K |
| AMGNAMGEN INC | 1,667 | $587K |
| GILDGILEAD SCIENCES, INC. | 4,012 | $559K |
| BMYBRISTOL MYERS SQUIBB CO | 6,363 | $386K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,287 | $348K |
| NVSNovartis AG | 1,967 | $300K |
| DVADaVita Inc. | 1,378 | $212K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.